Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
24761 | 252 | 30.4 | 75% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
540 | 13989 | FLUOROQUINOLONES//CIPROFLOXACIN//QUINOLONES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | EQUIPE ACCUEIL EA 3105 | Address | 2 | 67% | 1% | 2 |
2 | ESCHERICHIA COLI WP2UVRA PKM101 | Author keyword | 2 | 67% | 1% | 2 |
3 | DIRECC INVEST ENSENANZA | Address | 1 | 30% | 1% | 3 |
4 | AVENIR R05230HS | Address | 1 | 33% | 1% | 2 |
5 | BGU CANC | Address | 1 | 23% | 1% | 3 |
6 | CAS 124858 35 1 | Author keyword | 1 | 50% | 0% | 1 |
7 | CHAIR GEN ONCOL PEDIAT UROL | Address | 1 | 50% | 0% | 1 |
8 | EIWITBIOCHEM BIOMOL ENGN | Address | 1 | 50% | 0% | 1 |
9 | GENOTOXICITY THRESHOLDS | Author keyword | 1 | 50% | 0% | 1 |
10 | HEPATOCARCINOMA CELL LINE | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 4 BACTERIAL STRAINS | 1 | 50% | 1% | 2 |
2 | 750 MG | 1 | 50% | 1% | 2 |
3 | CHEMICALLY INDUCED MUTATION | 1 | 50% | 1% | 2 |
4 | SYNTHETIC QUINOLONE | 1 | 50% | 1% | 2 |
5 | TA2638 | 1 | 100% | 1% | 2 |
6 | WP2 PKM101 | 1 | 100% | 1% | 2 |
7 | SUBLETHALLY IRRADIATED MICE | 1 | 17% | 3% | 7 |
8 | 4 QUINOLONES | 1 | 10% | 4% | 10 |
9 | WP2 UVRA PKM101 | 1 | 33% | 1% | 2 |
10 | CARCINOMA IN VITRO | 1 | 16% | 2% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Immunomodulatory activities of fluoroquinolones | 2005 | 67 | 108 | 41% |
Immunomodulatory effects of quinolones | 2003 | 134 | 100 | 43% |
Does ciprofloxacin have an obverse and a reverse? | 2010 | 5 | 38 | 39% |
INHIBITORY EFFECTS OF QUINOLONE ANTIBACTERIAL AGENTS ON EUKARYOTIC TOPOISOMERASES AND RELATED TEST SYSTEMS | 1990 | 65 | 36 | 25% |
Using antimicrobial adjuvant therapy in cancer treatment: a review | 2012 | 4 | 62 | 8% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EQUIPE ACCUEIL EA 3105 | 2 | 67% | 0.8% | 2 |
2 | DIRECC INVEST ENSENANZA | 1 | 30% | 1.2% | 3 |
3 | AVENIR R05230HS | 1 | 33% | 0.8% | 2 |
4 | BGU CANC | 1 | 23% | 1.2% | 3 |
5 | CHAIR GEN ONCOL PEDIAT UROL | 1 | 50% | 0.4% | 1 |
6 | EIWITBIOCHEM BIOMOL ENGN | 1 | 50% | 0.4% | 1 |
7 | NEW YORK P BYTERIAN CORNELL MED | 1 | 50% | 0.4% | 1 |
8 | CHAIR MED BIOL | 1 | 13% | 1.6% | 4 |
9 | FOR OR | 0 | 33% | 0.4% | 1 |
10 | GEN ONCOL PEDIAT UROL | 0 | 33% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000210899 | HEAT SHOCK PROTECTION//ADP RIBOSEPOLYMERASE//CHICKEN EMBRYO CELLS |
2 | 0.0000206648 | CEFODIZIME//SUBINHIBITORY CONCENTRATIONS//BRODIMOPRIM |
3 | 0.0000190907 | ANTOFLOXACIN HYDROCHLORIDE//SKELETAL TOXICITY//ANTOFLOXACIN |
4 | 0.0000169954 | ALKALINE PHOSPHATE ACTIVITY//IN VIVO SENSITIZATION//SYNTHETIC LIPID |
5 | 0.0000148117 | N SUBSTITUTED PIPERAZINYL QUINOLONES//PIPERAZINYL QUINOLONES//S ENOKI 3394 |
6 | 0.0000116998 | INTERACTION WITH CALF THYMUS DNA//COMPETITIVE STUDIES WITH ETHIDIUM BROMIDE//NORFLOXACIN |
7 | 0.0000116454 | DIFFUSE PANBRONCHIOLITIS//ROXITHROMYCIN//AZITHROMYCIN |
8 | 0.0000110735 | RUFLOXACIN//ONCE A DAY ADMINISTRATION//RUFLOXACIN HYDROCHLORIDE |
9 | 0.0000103101 | LB20304//AT 4140//TEMAFLOXACIN |
10 | 0.0000088599 | SI PHARMACOL TOXICOL//MICRONUCLEI INDUCED//TUBERCULOSIS CHEMOTHERAPY |